Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development

Theranostics
Yun-Chieh SungYunching Chen

Abstract

Liver damage and fibrosis are precursors of hepatocellular carcinoma (HCC). In HCC patients, sorafenib-a multikinase inhibitor drug-has been reported to exert anti-fibrotic activity. However, incomplete inhibition of RAF activity by sorafenib may also induce paradoxical activation of the mitogen-activated protein kinase (MAPK) pathway in malignant cells. The consequence of this effect in non-malignant disease (hepatic fibrosis) remains unknown. This study aimed to examine the effects of sorafenib on activated hepatic stellate cells (HSCs), and develop effective therapeutic approaches to treat liver fibrosis and prevent cancer development. Methods: We first examined the effects of sorafenib in combination with MEK inhibitors on fibrosis pathogenesis in vitro and in vivo. To improve the bioavailability and absorption by activated HSCs, we developed CXCR4-targeted nanoparticles (NPs) to co-deliver sorafenib and a MEK inhibitor to mice with liver damage. Results: We found that sorafenib induced MAPK activation in HSCs, and promoted their myofibroblast differentiation. Combining sorafenib with a MEK inhibitor suppressed both paradoxical MAPK activation and HSC activation in vitro, and alleviated liver fibrosis in a CCl4-induced muri...Continue Reading

Citations

Apr 28, 2018·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Ying XieDavid Oupický
Feb 6, 2020·International Journal of Cancer. Journal International Du Cancer·Qi RuanXiaowen Liang
Sep 11, 2019·Journal of Experimental & Clinical Cancer Research : CR·Yaojie FuHong Shen
Sep 24, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Antonio PesceKatia Mangano
Aug 28, 2020·Frontiers in Cell and Developmental Biology·Anna E BarryHien Dang
Sep 28, 2018·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Qianyuan HeZushun Xu
Sep 25, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hanh Thuy NguyenJong Oh Kim
Feb 25, 2020·Current Molecular Pharmacology·Mengna WuWenjie Zheng
Jul 3, 2021·International Journal of Molecular Sciences·Eleonora RussoChiara Brullo
Aug 14, 2021·Frontiers in Cell and Developmental Biology·Sheng WangXiongwen Lv
Sep 3, 2020·Acta Pharmaceutica Sinica. B·Somayeh MahdinlooParvin Zakeri-Milani

❮ Previous
Next ❯

Methods Mentioned

BETA
nanoprecipitation

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.